X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.prnewswire.com/news-releases/immunic-announces-publication-of-extended-data-from-phase-2-emphasis-trial-of-vidofludimus-calcium-in-relapsing-remitting-multiple-sclerosis-in-the-peer-reviewed-journal-neurology-neuroimmunology--neuroinflammation-302131101.html
https://www.prnewswire.com/news-releases/effecticals-exceptional-efficacy-as-a-calcium-supplement-301910267.html
https://www.biospace.com/article/releases/u-s-fda-grants-orphan-drug-exclusivity-ode-for-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-for-idiopathic-hypersomnia-in-adults/
https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-sleep-publication-of-phase-3-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-study-in-cataplexy-or-excessive-daytime-sleepiness-in-patients-with-narcolepsy-301155706.html
https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-present-new-data-on-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-and-sunosi-solriamfetol-at-virtual-sleep-2020-301119658.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212690
https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-us-fda-approval-of-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-for-cataplexy-or-excessive-daytime-sleepiness-associated-with-narcolepsy-301097861.html
https://www.prnewswire.com/news-releases/european-commission-approves-expanded-indication-for-amgens-xgeva-denosumab-for-the-prevention-of-skeletal-related-events-in-patients-with-multiple-myeloma-300623000.html
http://www.pharmatimes.com/news/six_new_medicines_endorsed_for_eu_approval_1187675
http://www.financialexpress.com/lifestyle/health/artificial-insulin-producing-cells-may-help-manage-diabetes/471916/
http://www.business-standard.com/article/pti-stories/aurobindo-arm-to-acquire-select-products-in-france-from-teva-116112500990_1.html?
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/torrent-pharmaceuticals-shelcal-500-found-substandard-co-claims-it-was-counterfeited/articleshow/55378227.cms
http://www.expressbpd.com/pharma/latest-updates/marksans-pharma-gets-us-fda-nod-for-paricalcitol-drug/377830/
https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-1june2016-1464785216.pdf
http://www.pharma-excipients.ch/2016/01/28/the-influence-of-hydrophylic-polymers-on-the-release-rate-of-calcium-dobesilate-in-hydrogel-formulation-assessed-in-vitro-using-porcine-ear-skin/
http://www.moneycontrol.com/news/business/elder-pharma-eyes-rs-100crglobal-salesshelcal_1447521.html
http://www.bloomberg.com/news/2015-01-23/shire-s-5-2-billion-gamble-pays-off-as-nps-drug-wins-approval.html
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0301-2015&w=12242014&lang=eng
Market Place
Share 
